ClinicalTrials.gg
Drug

Pravastatin clinical trials

Also written Pravachol.

studies test it
96
open now
5
in phase 3
12
first study started
1994

How each study uses Pravastatin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Pravastatin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Oct 1991 · PRAVACHOL · NDA 019898 (FDA, Drugs@FDA)
European Union
14 Apr 2011 · Pravafenix · EMEA/H/C/001243 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pravastatin
63
pravastatin sodium
14
Pravachol 80 mg tablets
3
Pravastatin (drug)
2
Pravastatin 40 mg
2

Brand

Pravachol
16

In one entry with another drug

Given together, or one or the other

Sorafenib + Pravastatin
2

Studies by the year they started

94 studies that test it; most in 2008 (7)

Studies that test Pravastatin, by start year
YearStudies
19941
19981
19991
20004
20012
20025
20034
20044
20055
20063
20076
20087
20096
20105
20117
20123
20133
20143
20154
20161
20171
20184
20192
20204
20211
20231
20242
20253
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
29
Phase 2
20
Phase 3
12
Phase 4
28
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 72

Teva Pharmaceuticals USA (4) · University of Colorado, Denver (3) · Fred Hutchinson Cancer Center (3) · AstraZeneca (3) · University Hospital, Bordeaux (2) · Mylan Pharmaceuticals Inc (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Sanofi (2)

Often tested with

Tested in the same studies.

Atorvastatin (9) · Simvastatin (7) · Rosuvastatin (5) · Fenofibrate (4) · Metoprolol (3) · Fluvastatin (3) · Cytarabine (3) · Idarubicin (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Pravastatin.

Studies

Open first, then newest update. How each study uses Pravastatin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 96

See all 96 studies that test Pravastatin →

Given beside what is tested · 10 — Pravastatin is usual care or a partner of the new treatment
As the comparator · 23 — what is tested is compared with Pravastatin

Showing 20 of 23.

Codes

What other systems call Pravastatin · ClinicalTrials.gg INT008554

  • MeSH (NLM) D017035PravastatinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) KXO2KT9N0GPRAVASTATINConfirmed FDA, NLM, Wikidata
  • RxNorm 42463Confirmed FDA, Wikidata
  • Wikidata Q1240093pravastatinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62070PravastatinOne source FDA
  • DrugBank DB00175One source Wikidata

Also registered as pravastatin sodium (UNII 3M8608UQ61 · RxNorm 203144).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.